463 related articles for article (PubMed ID: 33024971)
1. Genome-Wide Asymptomatic B-Cell, CD4
Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
bioRxiv; 2020 Sep; ():. PubMed ID: 33024971
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide B Cell, CD4
Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection induced by highly conserved human B, CD4
Prakash S; Dhanushkodi NR; Zayou L; Ibraim IC; Quadiri A; Coulon PG; Tifrea DF; Suzer B; Shaik AM; Chilukuri A; Edwards RA; Singer M; Vahed H; Nesburn AB; Kuppermann BD; Ulmer JB; Gil D; Jones TM; BenMohamed L
Front Immunol; 2024; 15():1328905. PubMed ID: 38318166
[TBL] [Abstract][Full Text] [Related]
4. Cross-Protection Induced by Highly Conserved Human B, CD4
Prakash S; Dhanushkodi NR; Zayou L; Ibraim IC; Quadiri A; Coulon PG; Tifrea DF; Suzler B; Amin M; Chilukuri A; Edwards RA; Vahed H; Nesburn AB; Kuppermann BD; Ulmer JB; Gil D; Jones TM; BenMohamed L
bioRxiv; 2023 May; ():. PubMed ID: 37292861
[TBL] [Abstract][Full Text] [Related]
5. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4
Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L
Front Immunol; 2024; 15():1343716. PubMed ID: 38605956
[TBL] [Abstract][Full Text] [Related]
6. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
[TBL] [Abstract][Full Text] [Related]
7. A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model.
Prakash S; Dhanushkodi NR; Singer M; Quadiri A; Zayou L; Vahed H; Coulon PG; Ibraim IC; Tafoya C; Hitchcock L; Landucci G; Forthal DN; El Babsiri A; Tifrea DF; Figueroa CJ; Nesburn AB; Kuppermann BD; Gil D; Jones TM; Ulmer JB; BenMohamed L
bioRxiv; 2024 Feb; ():. PubMed ID: 38405942
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
9. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.
Zhao J; Zhao J; Mangalam AK; Channappanavar R; Fett C; Meyerholz DK; Agnihothram S; Baric RS; David CS; Perlman S
Immunity; 2016 Jun; 44(6):1379-91. PubMed ID: 27287409
[TBL] [Abstract][Full Text] [Related]
10. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
11. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
12. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.
Ng OW; Chia A; Tan AT; Jadi RS; Leong HN; Bertoletti A; Tan YJ
Vaccine; 2016 Apr; 34(17):2008-14. PubMed ID: 26954467
[TBL] [Abstract][Full Text] [Related]
13. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife.
Islam A; Ferdous J; Islam S; Sayeed MA; Dutta Choudhury S; Saha O; Hassan MM; Shirin T
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696338
[TBL] [Abstract][Full Text] [Related]
15. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
Ahmad F; Kamal MA; Tekwani BL
Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses.
Woldemeskel BA; Dykema AG; Garliss CC; Cherfils S; Smith KN; Blankson JN
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35061630
[TBL] [Abstract][Full Text] [Related]
17. Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches.
Baloch Z; Ikram A; Shamim S; Obaid A; Awan FM; Naz A; Rauff B; Gilani K; Qureshi JA
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891314
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome (SARS) related coronavirus in bats.
Geng R; Zhou P
Anim Dis; 2021; 1(1):4. PubMed ID: 34778877
[TBL] [Abstract][Full Text] [Related]
19. Antivirals for Broader Coverage against Human Coronaviruses.
Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
[TBL] [Abstract][Full Text] [Related]
20. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]